Lexaria Bioscience Corp Stock Buy Hold or Sell Recommendation
| LEXX Stock | USD 2.08 0.01 0.48% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Lexaria Bioscience Corp is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Lexaria Bioscience Corp given historical horizon and risk tolerance towards Lexaria Bioscience. When Macroaxis issues a 'buy' or 'sell' recommendation for Lexaria Bioscience Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Lexaria Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Lexaria and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Lexaria |
Execute Lexaria Bioscience Buy or Sell Advice
The Lexaria recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lexaria Bioscience Corp. Macroaxis does not own or have any residual interests in Lexaria Bioscience Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lexaria Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Lexaria Bioscience Trading Alerts and Improvement Suggestions
| Lexaria Bioscience generated a negative expected return over the last 90 days | |
| Lexaria Bioscience has high historical volatility and very poor performance | |
| Lexaria Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 464.28 K. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 183.56 K. | |
| Lexaria Bioscience Corp currently holds about 7.34 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.23. | |
| Lexaria Bioscience has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Disposition of 200000 shares by Richard Christopher of Lexaria Bioscience at 3.92 subject to Rule 16b-3 |
Lexaria Bioscience Returns Distribution Density
The distribution of Lexaria Bioscience's historical returns is an attempt to chart the uncertainty of Lexaria Bioscience's future price movements. The chart of the probability distribution of Lexaria Bioscience daily returns describes the distribution of returns around its average expected value. We use Lexaria Bioscience Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lexaria Bioscience returns is essential to provide solid investment advice for Lexaria Bioscience.
| Mean Return | -0.42 | Value At Risk | -6.19 | Potential Upside | 7.91 | Standard Deviation | 4.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lexaria Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lexaria Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Lexaria Bioscience, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Lexaria Bioscience Corp back and forth among themselves.
| Shares | Wealth Enhancement Advisory Services, Llc | 2024-09-30 | 13.8 K | Royal Bank Of Canada | 2024-06-30 | 7.3 K | Oakworth Capital Inc | 2024-09-30 | 5 K | Tower Research Capital Llc | 2024-06-30 | 3.4 K | Wells Fargo & Co | 2024-06-30 | 3.3 K | Advisor Group Holdings, Inc. | 2024-06-30 | 2.3 K | Aspire Private Capital, Llc | 2024-09-30 | 400 | Mather Group, Inc. | 2024-06-30 | 100.0 | Bank Of America Corp | 2024-06-30 | 96.0 | Invenomic Capital Management, Lp | 2024-09-30 | 475.8 K | Geode Capital Management, Llc | 2024-09-30 | 150.4 K |
Lexaria Bioscience Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 8.6K | 9.6M | (5.1M) | (4.5M) | 5.1M | 5.4M | |
| Free Cash Flow | (2.7M) | (4.1M) | (5.0M) | (6.1M) | (5.0M) | (4.7M) | |
| Capital Expenditures | 769.2K | 33.6K | 79.5K | 131.4K | 169.6K | 0.0 | |
| Net Income | (4.1M) | (4.2M) | (7.4M) | (6.7M) | (5.8M) | (5.5M) | |
| End Period Cash Flow | 1.3M | 10.9M | 5.8M | 1.4M | 6.5M | 6.8M | |
| Depreciation | 112.8K | 147.6K | 141.3K | 145.4K | 76.2K | 85.9K | |
| Other Non Cash Items | 100K | 92.9K | 2.0M | 530.3K | 174.7K | 166.0K | |
| Change To Inventory | 4.2K | 95.0K | (2.0K) | 43.1K | 49.5K | 52.0K | |
| Change To Netincome | 953.6K | 1.3M | (173.8K) | 2.6M | 2.3M | 1.3M |
Lexaria Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lexaria Bioscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lexaria Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lexaria stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | 1.28 | |
σ | Overall volatility | 3.31 | |
Ir | Information ratio | -0.12 |
Lexaria Bioscience Volatility Alert
Lexaria Bioscience Corp exhibits very low volatility with skewness of 2.01 and kurtosis of 7.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lexaria Bioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lexaria Bioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Lexaria Bioscience Fundamentals Vs Peers
Comparing Lexaria Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lexaria Bioscience's direct or indirect competition across all of the common fundamentals between Lexaria Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lexaria Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lexaria Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lexaria Bioscience to competition |
| Fundamentals | Lexaria Bioscience | Peer Average |
| Return On Equity | -0.71 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Operating Margin | (20.75) % | (5.51) % |
| Current Valuation | 29.88 M | 16.62 B |
| Shares Outstanding | 17.45 M | 571.82 M |
| Shares Owned By Insiders | 7.00 % | 10.09 % |
| Shares Owned By Institutions | 6.00 % | 39.21 % |
| Number Of Shares Shorted | 342.37 K | 4.71 M |
| Price To Book | 4.52 X | 9.51 X |
| Price To Sales | 88.75 X | 11.42 X |
| Revenue | 464.28 K | 9.43 B |
| Gross Profit | 183.56 K | 27.38 B |
| EBITDA | (5.75 M) | 3.9 B |
| Net Income | (5.81 M) | 570.98 M |
| Cash And Equivalents | 7.34 M | 2.7 B |
| Cash Per Share | 1.23 X | 5.01 X |
| Total Debt | 137.37 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 40.09 X | 2.16 X |
| Book Value Per Share | 0.64 X | 1.93 K |
| Cash Flow From Operations | (4.96 M) | 971.22 M |
| Short Ratio | 2.34 X | 4.00 X |
| Earnings Per Share | (0.47) X | 3.12 X |
| Target Price | 10.0 | |
| Number Of Employees | 5 | 18.84 K |
| Beta | 1.06 | -0.15 |
| Market Capitalization | 36.48 M | 19.03 B |
| Total Asset | 8.87 M | 29.47 B |
| Retained Earnings | (51.56 M) | 9.33 B |
| Working Capital | 1.93 M | 1.48 B |
| Net Asset | 8.87 M |
Note: Disposition of 200000 shares by Richard Christopher of Lexaria Bioscience at 3.92 subject to Rule 16b-3 [view details]
Lexaria Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lexaria . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Lexaria Bioscience Buy or Sell Advice
When is the right time to buy or sell Lexaria Bioscience Corp? Buying financial instruments such as Lexaria Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lexaria Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Defence Thematic Idea Now
Aggressive Defence
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.